The downregulation of LOX is unexpected, given its established role in enhancing glioma invasiveness via extracellular matrix crosslinking and remodeling through enhancing epidermal growth factor receptor (EGFR) signaling92–94. The gene discussed is EGFR; the disease is central nervous system cancer.